{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T16:31:25Z","timestamp":1744907485184,"version":"3.32.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T00:00:00Z","timestamp":1693958400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.cyto.2023.156350","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:12:41Z","timestamp":1693872761000},"page":"156350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Inflammatory and cytotoxic mediators in COVID-19 patients and in ChAdOx1 nCoV-19 (AZD1222) vaccine recipients"],"prefix":"10.1016","volume":"171","author":[{"given":"D\u00e9bora","family":"Familiar-Macedo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo","family":"Vieira Damasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor Edgar","family":"Fiestas Sol\u00f3rzano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce","family":"Carnevale Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elba Regina","family":"Sampaio de Lemos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fl\u00e1via","family":"Barreto dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilda","family":"Agudo Mendon\u00e7a Teixeira de Siqueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elzinandes","family":"Leal de Azeredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luzia Maria","family":"de-Oliveira-Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10225","key":"10.1016\/j.cyto.2023.156350_b0005","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(20)30260-9","article-title":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study [published correction appears in Lancet. 2020 Feb 4;:]","volume":"395","author":"Wu","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.cyto.2023.156350_b0010","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3390\/jcm9020575","article-title":"Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China","volume":"9","author":"Deng","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cyto.2023.156350_b0015","unstructured":"World Health Organization. WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data. Accessed on February 05, 2023. Available from: https:\/\/covid19.who.int\/."},{"issue":"3","key":"10.1016\/j.cyto.2023.156350_b0020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol"},{"key":"10.1016\/j.cyto.2023.156350_b0025","doi-asserted-by":"crossref","unstructured":"Y. Dong, T. Dai, Y. Wei, L. Zhang, M. Zheng, F. Zhou, A systematic review of SARS-CoV-2 vaccine candidates, Signal Transduct, Target Ther. 2020;5(1):237. Published 2020 Oct 13. doi:10.1038\/s41392-020-00352-y.","DOI":"10.1038\/s41392-020-00352-y"},{"key":"10.1016\/j.cyto.2023.156350_b0030","doi-asserted-by":"crossref","unstructured":"A. Pormohammad, M. Zarei, S. Ghorbani, et al. Efficacy and safety of COVID-19 vaccines: a systematic review and meta-analysis of randomized clinical trials. Vaccines (Basel). 2021;9(5):467. Published 2021 May 6. doi:10.3390\/vaccines9050467.","DOI":"10.3390\/vaccines9050467"},{"key":"10.1016\/j.cyto.2023.156350_b0035","doi-asserted-by":"crossref","unstructured":"M. Voysey, S.A.C. Clemens, S.A. Madhi, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK [published correction appears in Lancet. 2021 Jan 9;397(10269):98]. Lancet. 2021;397(10269):99-111. doi:10.1016\/S0140-6736(20)32661-1.","DOI":"10.1016\/S0140-6736(20)32661-1"},{"key":"10.1016\/j.cyto.2023.156350_b0040","doi-asserted-by":"crossref","unstructured":"J.R. Teijaro, D.L. Farber, COVID-19 vaccines: modes of immune activation and future challenges, Nat. Rev. Immunol. 2021;21(4):195-197. doi:10.1038\/s41577-021-00526-x.","DOI":"10.1038\/s41577-021-00526-x"},{"issue":"1\u20132","key":"10.1016\/j.cyto.2023.156350_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2007.10.005","article-title":"Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications","volume":"132","author":"Hartman","year":"2008","journal-title":"Virus. Res."},{"issue":"15","key":"10.1016\/j.cyto.2023.156350_b0050","doi-asserted-by":"crossref","first-page":"e2004433","DOI":"10.1002\/advs.202004433","article-title":"Cytokines: From Clinical Significance to Quantification","volume":"8","author":"Liu","year":"2021","journal-title":"Adv. Sci. (Weinh)."},{"key":"10.1016\/j.cyto.2023.156350_b0055","doi-asserted-by":"crossref","unstructured":"S.A. Vardhana, J.D. Wolchok, The many faces of the anti-COVID immune response, J, Exp, Med. 2020;217(6):e20200678. doi:10.1084\/jem.20200678.","DOI":"10.1084\/jem.20200678"},{"issue":"6504","key":"10.1016\/j.cyto.2023.156350_b0060","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science."},{"issue":"1","key":"10.1016\/j.cyto.2023.156350_b0065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jaci.2020.04.027","article-title":"Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19","volume":"146","author":"Yang","year":"2020","journal-title":"J. Allergy. Clin. Immunol."},{"issue":"7821","key":"10.1016\/j.cyto.2023.156350_b0070","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal analyses reveal immunological misfiring in severe COVID-19","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.cyto.2023.156350_b0075","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41423-020-0401-3","article-title":"Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"11","key":"10.1016\/j.cyto.2023.156350_b0080","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/infdis\/jiaa150","article-title":"Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia","volume":"221","author":"Wang","year":"2020","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.cyto.2023.156350_b0085","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41423-020-0402-2","article-title":"Functional exhaustion of antiviral lymphocytes in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"580237","key":"10.1016\/j.cyto.2023.156350_b0090","first-page":"2020","article-title":"Elevated Exhaustion Levels of NK and CD8+ T Cells as Indicators for Progression and Prognosis of COVID-19 Disease","volume":"11","author":"Li","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2023.156350_b0095","doi-asserted-by":"crossref","unstructured":"M. Yang, C. Lin, Y. Wang, et al., Cytokine storm promoting T cell exhaustion in severe COVID-19 revealed by single cell sequencing data analysis. Precis Clin. Med. 2022;5(2):pbac014. Published 2022 May 23. doi:10.1093\/pcmedi\/pbac014.","DOI":"10.1093\/pcmedi\/pbac014"},{"issue":"5","key":"10.1016\/j.cyto.2023.156350_b0100","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1615\/CritRevImmunol.2014010604","article-title":"NK cells and their ability to modulate T cells during virus infections","volume":"34","author":"Cook","year":"2014","journal-title":"Crit. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2023.156350_b0105","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41577-021-00558-3","article-title":"Natural killer cells in antiviral immunity","volume":"22","author":"Bj\u00f6rkstr\u00f6m","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2023.156350_b0110","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3390\/v14030455","article-title":"Comparative Analysis of Circulating Levels of SARS-CoV-2 Antibodies and Inflammatory Mediators in Healthcare Workers and COVID-19 Patients","volume":"14","author":"de-Oliveira-Pinto","year":"2022","journal-title":"Viruses."},{"issue":"10","key":"10.1016\/j.cyto.2023.156350_b0115","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1007\/s00253-021-11319-6","article-title":"Potential role of IFN-\u03b1 in COVID-19 patients and its underlying treatment options","volume":"105","author":"Yang","year":"2021","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"1","key":"10.1016\/j.cyto.2023.156350_b0120","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1515\/bmc-2018-0007","article-title":"Interferon-gamma (IFN-\u03b3): Exploring its implications in infectious diseases","volume":"9","author":"Kak","year":"2018","journal-title":"Biomol. Concepts."},{"issue":"25","key":"10.1016\/j.cyto.2023.156350_b0125","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aat1482","article-title":"Biology and therapeutic prospects","volume":"3","author":"Abbas","year":"2018","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.cyto.2023.156350_b0130","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-94-024-0921-5_3","article-title":"Regulation of IL-4 Expression in Immunity and Diseases","volume":"941","author":"Ho","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"issue":"6","key":"10.1016\/j.cyto.2023.156350_b0135","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41584-020-0419-z","article-title":"Translating IL-6 biology into effective treatments","volume":"16","author":"Choy","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.cyto.2023.156350_b0140","doi-asserted-by":"crossref","unstructured":"I.A. Paiva, J. Badolato-Corr\u00eaa, D. Familiar-Macedo, L.M. de-Oliveira-Pinto, Th17 Cells in Viral Infections-Friend or Foe?. Cells. 2021;10(5):1159. Published 2021 May 11. doi:10.3390\/cells10051159.","DOI":"10.3390\/cells10051159"},{"issue":"3","key":"10.1016\/j.cyto.2023.156350_b0145","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H","article-title":"TNF alpha and the TNF receptor superfamily: structure-function relationship(s)","volume":"50","author":"Idriss","year":"2000","journal-title":"Microsc. Res. Tech."},{"issue":"5","key":"10.1016\/j.cyto.2023.156350_b0150","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/febs.14292","article-title":"Nonapoptotic functions of Fas\/CD95 in the immune response","volume":"285","author":"Gu\u00e9gan","year":"2018","journal-title":"FEBS. J."},{"issue":"6","key":"10.1016\/j.cyto.2023.156350_b0155","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nri3839","article-title":"Perforin and granzymes: function, dysfunction and human pathology","volume":"15","author":"Voskoboinik","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2023.156350_b0160","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.imlet.2019.11.005","article-title":"Granulysin: The attractive side of a natural born killer","volume":"217","author":"Sparrow","year":"2020","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.cyto.2023.156350_b0165","unstructured":"Minist\u00e9rio da Sa\u00fade . Guia de Vigil\u00e2ncia Epidemiol\u00f3gica Emerg\u00eancia de Sa\u00fade P\u00fablica de Import\u00e2ncia Nacional Pela Doen\u00e7a Pelo Coronavirus. Ministerio da Sa\u00fade; Bras\u00edlia, Brasil, 2022."},{"issue":"10","key":"10.1016\/j.cyto.2023.156350_b0170","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1172\/JCI138759","article-title":"Kinetics of viral load and antibody response in relation to COVID-19 severity","volume":"130","author":"Wang","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2023.156350_b0175","doi-asserted-by":"crossref","unstructured":"A.T. Huang, B. Garcia-Carreras, M.D.T. Hitchings, et al. A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity. Nat. Commun. 2020;11(1):4704. Published 2020 Sep 17. doi:10.1038\/s41467-020-18450-4.","DOI":"10.1038\/s41467-020-18450-4"},{"issue":"7821","key":"10.1016\/j.cyto.2023.156350_b0180","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41586-020-2548-6","article-title":"Potently neutralizing and protective human antibodies against SARS-CoV-2","volume":"584","author":"Zost","year":"2020","journal-title":"Nature."},{"issue":"7819","key":"10.1016\/j.cyto.2023.156350_b0185","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-020-2380-z","article-title":"Human neutralizing antibodies elicited by SARS-CoV-2 infection","volume":"584","author":"Ju","year":"2020","journal-title":"Nature."},{"key":"10.1016\/j.cyto.2023.156350_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108215","article-title":"Serological anti-SARS-CoV-2 neutralizing antibodies association to live virus neutralizing test titers in COVID-19 paucisymptomatic\/symptomatic patients and vaccinated subjects","volume":"101","author":"Cristiano","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.cyto.2023.156350_b0195","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3904\/kjim.2021.409","article-title":"Comparison of antibody responses after the 1st and 2nd doses of COVID-19 vaccine with those of patients with mild or severe COVID-19","volume":"37","author":"Cha","year":"2022","journal-title":"Korean. J. Intern. Med."},{"issue":"47","key":"10.1016\/j.cyto.2023.156350_b0200","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1016\/j.vaccine.2016.08.051","article-title":"An inflammatory response is essential for the development of adaptive immunity-immunogenicity and immunotoxicity","volume":"34","author":"Nakayama","year":"2016","journal-title":"Vaccine."},{"key":"10.1016\/j.cyto.2023.156350_b0205","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbrc.2020.10.060","article-title":"T cell immunity to SARS-CoV-2 following natural infection and vaccination","volume":"538","author":"DiPiazza","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.cyto.2023.156350_b0210","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-020-01194-5","article-title":"T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1\/2 clinical trial","volume":"27","author":"Ewer","year":"2021","journal-title":"Nat. Med"},{"issue":"2","key":"10.1016\/j.cyto.2023.156350_b0215","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41591-020-01179-4","article-title":"Phase 1\/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses","volume":"27","author":"Barrett","year":"2021","journal-title":"Nat. Med"},{"key":"10.1016\/j.cyto.2023.156350_b0220","doi-asserted-by":"crossref","unstructured":"T. Azamor, I.S. Horbach, E. Brito, D. Cunha, et al. Protective Immunity of COVID-19 Vaccination with ChAdOx1 nCoV-19 Following Previous SARS-CoV-2 Infection: A Humoral and Cellular Investigation. Viruses. 2022;14(9):1916. Published 2022 Aug 30. doi:10.3390\/v14091916.","DOI":"10.3390\/v14091916"},{"key":"10.1016\/j.cyto.2023.156350_b0225","doi-asserted-by":"crossref","unstructured":"J.Y. Heo, Y.B. Seo, E.J. Kim, et al. COVID-19 vaccine type-dependent differences in immunogenicity and inflammatory response: BNT162b2 and ChAdOx1 nCoV-19. Front. Immunol. 2022;13:975363. Published 2022 Sep 2. doi:10.3389\/fimmu.2022.975363.","DOI":"10.3389\/fimmu.2022.975363"},{"issue":"11","key":"10.1016\/j.cyto.2023.156350_b0230","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.1002\/jmv.28012","article-title":"Single-cell transcriptomic atlas reveals distinct immunological responses between COVID-19 vaccine and natural SARS-CoV-2 infection","volume":"94","author":"Wang","year":"2022","journal-title":"J. Med. Virol."},{"issue":"6","key":"10.1016\/j.cyto.2023.156350_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2022.152288","article-title":"IL-6, IL-10, sFas, granulysin and indicators of intestinal permeability as early biomarkers for a fatal outcome in COVID-19","volume":"227","author":"Hern\u00e1ndez-Solis","year":"2022","journal-title":"Immunobiology."},{"issue":"9","key":"10.1016\/j.cyto.2023.156350_b0240","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/s41590-020-0762-x","article-title":"Single-cell landscape of immunological responses in patients with COVID-19","volume":"21","author":"Zhang","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cyto.2023.156350_b0245","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.795315","article-title":"Immunotherapy of COVID-19: Inside and Beyond IL-6 Signalling","volume":"13","author":"Zizzo","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466623002284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466623002284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T10:07:01Z","timestamp":1736417221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466623002284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":49,"alternative-id":["S1043466623002284"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156350","relation":{},"ISSN":["1043-4666"],"issn-type":[{"type":"print","value":"1043-4666"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammatory and cytotoxic mediators in COVID-19 patients and in ChAdOx1 nCoV-19 (AZD1222) vaccine recipients","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156350","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"156350"}}